MYO
What one share of Myomo holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb paralysis. We develop and market the MyoPro product line. A MyoPro is a myoelectric-controlled upper limb brace, or orthosis.
Myomo’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.02 |
|---|---|
| Profit | −$0.34 |
| Capex (buildings and equipment) | $0.03 |
| Free cash flow | −$0.20 |
| Cash and investments | $0.28 |
| Debt | $0.30 |
| Book value | $0.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $31.20 | −$123.97 | $0.05 | −$90.62 | — | −$467.86 |
| 2017 | $10.83 | −$87.96 | $0.47 | −$43.22 | — | — |
| 2018 | $5.96 | −$25.18 | $0.31 | −$23.75 | — | $15.48 |
| 2019 | $6.93 | −$20.79 | $0.09 | −$18.77 | — | $11.19 |
| 2020 | $2.28 | −$3.67 | $0.01 | −$2.73 | — | $2.52 |
| 2021 | $2.38 | −$1.89 | $0.06 | −$1.69 | — | $2.24 |
| 2022 | $2.21 | −$1.52 | $0.02 | −$1.47 | — | $0.82 |
| 2023 | $0.65 | −$0.28 | $0.00 | −$0.21 | — | $0.33 |
| 2024 | $0.86 | −$0.16 | $0.04 | −$0.12 | — | $0.72 |
| 2025 | $0.98 | −$0.37 | $0.04 | −$0.39 | — | $0.30 |